|Bid||0.0000 x 3100|
|Ask||0.0000 x 2200|
|Day's Range||2.7300 - 2.9200|
|52 Week Range||2.3500 - 5.4000|
|Beta (3Y Monthly)||1.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 28, 2019 - Nov 1, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Accuray (ARAY) delivered earnings and revenue surprises of -166.67% and 1.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
SUNNYVALE, Calif. , Aug. 15, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019 . Q4 Fiscal 2019 and Recent ...
Accuray (NASDAQ: ARAY ) unveils its next round of earnings this Thursday, August 15. Here is Benzinga's everything-that-matters guide for the earnings announcement. Earnings and Revenue Based on Accuray ...
In 2012 Joshua Levine was appointed CEO of Accuray Incorporated (NASDAQ:ARAY). First, this article will compare CEO...
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SUNNYVALE, Calif., July 24, 2019 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that studies validating the benefits of CyberKnife® and Radixact® System software innovations were shared by prominent physicists at the recent 61st annual meeting of the American Association of Physicists in Medicine (AAPM). "Accuray is dedicated to providing clinicians with solutions that enable them to achieve their clinical goals for patients at every stage of their cancer treatment journey," said Fabienne Hirigoyenberry-Lanson, Ph.D., vice president of global medical and scientific affairs at Accuray.
SUNNYVALE, Calif. , July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray ( Tianjin ) Medical Technology ...
SUNNYVALE, Calif. , July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after ...
SUNNYVALE, Calif., July 18, 2019 PRNewswire/ -- The Swiss Medical Network, one of Switzerland's two largest private hospital groups, has signed a multi-system, multi-clinic agreement to purchase Accuray Incorporated's radiation therapy delivery systems as well as RaySearch's treatment planning system (TPS) and oncology information system (OIS). This is the first multi-system agreement by a hospital for the purchase of both the Accuray and RaySearch products.
If you're interested in Accuray Incorporated (NASDAQ:ARAY), then you might want to consider its beta (a measure of...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The main aim of stock picking is to find the market-beating stocks. But every investor is virtua...
SUNNYVALE, Calif., May 1, 2019 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the company has signed an agreement with Hong Kong Sanatorium & Hospital (HKSH) for the acquisition of two Synchrony® motion tracking and correction technology upgrades, to be used with the hospital's Radixact® Systems. Synchrony is a sophisticated tool developed to make it easier to provide precise radiation treatments to all tumors, even those that move.
SUNNYVALE, Calif., April 24, 2019 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today the launch of its Synchrony® motion tracking and correction technology1 to be used with the Radixact® System. This new feature adds intrafraction motion synchronization capabilities to the Radixact System, enabling real-time tracking, visualization and correction for tumor motion during treatment, with the goal of improving dose accuracy and treatment times compared to conventional radiation therapy systems.